TAMPA, Fla.--(BUSINESS WIRE)--Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) announced today that the Company has filed its Quarterly Report (Form 10-Q) with the SEC, reporting the results of its operations, including consolidated results with its majority-owned subsidiary, Biovest International, Inc. (OTCBB:BVTI), for its second fiscal quarter ended March 31, 2008. The Company also announced that it is scheduled to present at the Jefferies & Co. 2nd Annual Healthcare Conference in New York City.
